CROSSJECT (EPA:ALCJ) | Finanzwire

Basculer en Français

11265	Companies
250246	Keywords
178707	Articles
136088	Press releases

Home
Companies
CROSSJECT

PRESS RELEASE

published on 03/25/2025 at 07:30, 1 year 7 months ago

CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program
CROSSJECT enhances collaboration with ETON PHARMACEUTICALS Inc. on ZENEO adrenal insufficiency program, introducing new hydrocortisone formulation for the hospital market

Eton Pharmaceuticals Crossject Hydrocortisone Adrenal Insufficiency ZENEO
BRIEF

published on 03/10/2025 at 14:22, 1 year 7 months ago

Crossject: Update on voting rights and shares as of January 31, 2025

Share Capital Voting Rights Actions Pharmaceutical Crossject
BRIEF

published on 02/12/2025 at 07:35, 1 year 8 months ago

Crossject Reappoints Key Members to Executive Board

Executive Board Crossject ZEPIZURE® Reappointment Needle-free Technology
PRESS RELEASE

published on 02/12/2025 at 07:30, 1 year 8 months ago

Crossject announces the reappointment of Patrick Alexandre and Isabelle Liebschutz as members of new, streamlined Executive Board
Crossject reappoints Patrick Alexandre and Isabelle Liebschutz to its Executive Board, focusing on final stages of ZEPIZURE registration with the FDA

Executive Board Crossject Patrick Alexandre Isabelle Liebschutz ZEPIZURE Registration
BRIEF

published on 02/06/2025 at 07:35, 1 year 8 months ago

Modification of Convertible Bonds by Crossject

Convertible Bonds Funding Crossject ZEPIZURE Heights Capital
PRESS RELEASE

published on 02/06/2025 at 07:30, 1 year 8 months ago

COMPLETION OF THE TRANSACTIONS ANNOUNCED IN DECEMBER 2024 RELATING TO THE AMENDMENT OF THE CONVERTIBLE BONDS SUBSCRIBED BY AN ENTITY AFFILIATED TO HEIGHTS CAPITAL MANAGEMENT, INC. (“HEIGHTS”) AND THE ISSUE OF A SECOND ASSIMILABLE TRANCHE
Crossject completes transactions announced in December 2024 related to amendment of convertible bonds subscribed by an entity affiliated to Heights Capital Management, Inc. Second assimilable tranche issued

Convertible Bonds Transaction Bond Issue Crossject Heights Capital Management
BRIEF

published on 01/20/2025 at 14:47, 1 year 9 months ago

Crossject: Update on voting rights and shares as of December 31, 2024

Share Capital Voting Rights Actions 2024 Crossject
BRIEF

published on 12/31/2024 at 10:02, 1 year 10 months ago

Crossject: Details on Share Capital and Voting Rights as of November 30, 2024

Share Capital Voting Rights Actions AMF Crossject
BRIEF

published on 12/19/2024 at 07:35, 1 year 10 months ago

Crossject Advances ZEPIZURE® Supply Chain Readiness

Supply Chain U.S. Market ISO 13485 Crossject ZEPIZURE®
PRESS RELEASE

published on 12/19/2024 at 07:30, 1 year 10 months ago

Crossject confirms ZEPIZURE® supply chain readiness with another successful ISO audit for Quality Management System
Crossject confirms readiness of ZEPIZURE® supply chain after successful ISO 13485 audit for manufacturing sites in Dijon and Gray (France), preparing for commercialization in the U.S

Supply Chain Commercialization Crossject ZEPIZURE ISO 13485 Audit

Accesswire

Published on 11/03/2026 at 14:00, 28 minutes ago

Global Education Communities Corp. Provides Corporate Update on Student Housing Portfolio and Development Projects
Published on 11/03/2026 at 13:48, 40 minutes ago

EonX Announces Strategic Technology Partnership with Metcash, Australia's Leading Wholesaler and Service Provider to Independent Business Operators
Published on 11/03/2026 at 13:35, 53 minutes ago

ESGold Expands Historic Mine Waste Reclamation Strategy With Second MOU, Bringing Total Proposed Annual Aggregate Supply to 500,000 Tonnes
Published on 11/03/2026 at 13:30, 58 minutes ago

Nextech3D.ai to Showcase AI-Powered Event Technology at IAEE Expo Expo 2026
Published on 11/03/2026 at 13:29, 59 minutes ago

Impauer Technologies Launches Pauerone Wallet V1 Desktop App Across Windows, MacOS, and Chrome OS to Deliver Isolated Self-custody

View all ACCESSWIRE

EQS Group

Published on 11/03/2026 at 13:00, 1 hour 28 minutes ago

QUANTRO Therapeutics secures key Austrian research grant to build its AI-powered drug discovery platform
Published on 11/03/2026 at 12:25, 2 hours 3 minutes ago

swissnet Group secures largest contract in company history worth approximately EUR 10 million
Published on 11/03/2026 at 12:10, 2 hours 18 minutes ago

LIPSIA-STRATEGY trial demonstrates non-inferiority of CAAS vFFR guided revascularization against pressure wire-based FFR revascularization
Published on 11/03/2026 at 12:00, 2 hours 28 minutes ago

Restoration - Pristine Capital Plc
Published on 11/03/2026 at 11:55, 2 hours 33 minutes ago

swissnet Group publishes H1 2026 results and lays foundation for profitable growth through successful restructuring

Les Echos

Published on 11/03/2026 at 07:00, 7 hours 28 minutes ago

bioMérieux – Third-Quarter 2026 Business Review
Published on 11/02/2026 at 21:08, 17 hours 20 minutes ago

GROUPE SFPI LIQUIDIDY CONTRAT H1 2026
Published on 11/02/2026 at 18:30, 19 hours 58 minutes ago

Disclosure of transactions in own shares from October 26 to October 30, 2026
Published on 11/02/2026 at 18:17, 20 hours 11 minutes ago

Reporting on share buyback transactions carried out between October 28 and October 29, 2026
Published on 11/02/2026 at 18:00, 20 hours 28 minutes ago

Covivio - Information on total number of voting rights and share capital

View all LES ECHOS COMFI WIRE